Molecular Mechanisms and Promising Role of Dihydromyricetin in Cardiovascular Diseases

被引:7
|
作者
Nie, Hao [1 ]
Ji, Tianyi [1 ]
Fu, Yu [1 ]
Chen, Danyang [2 ]
Tang, Zhouping [2 ]
Zhang, Cuntai [1 ,3 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Geriatr, Wuhan, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurol, Wuhan, Hubei, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Geriatr, Wuhan 430030, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
Dihydromyricetin; Cardiovascular disease; Atherosclerosis; Myocardial infarction; Myocardial hypertrophy; TEA AMPELOPSIS-GROSSEDENTATA; ENDOTHELIAL-CELLS; RAT PLASMA; LC-MS/MS; IN-VITRO; AUTOPHAGY; PROTECTS; METABOLISM; CARDIOMYOPATHY; IDENTIFICATION;
D O I
10.33549/physiolres.934915
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Vine tea, a Chinese herbal medicine, is widely used in traditional Asian medicine to treat common health problems. Dihydromyricetin (DMY) is the main functional flavonoid compound extracted from vine tea. In recent years, preclinical studies have focused on the potential beneficial effects of dihydromyricetin, including glucose metabolism regulation, lipid metabolism regulation, neuroprotection, and anti-tumor effects. In addition, DMY may play a role in cardiovascular disease by resisting oxidative stress and participating in the regulation of inflammation. This review is the first review that summaries the applications of dihydromyricetin in cardiovascular diseases, including atherosclerosis, myocardial infarction, myocardial hypertrophy, and diabetic cardiomyopathy. We also clarified the underlying mechanisms and signaling pathways involved in the above process. The aim of this review is to provide a better understanding and quick overview for future researches of dihydromyricetin in the field of cardiovascular diseases, and more detailed and robust researches are needed for evaluation and reference.
引用
收藏
页码:749 / 762
页数:14
相关论文
共 50 条
  • [1] Multitarget and promising role of dihydromyricetin in the treatment of metabolic diseases
    Tong, Haihui
    Zhang, Xuejun
    Tan, Lingfang
    Jin, Runming
    Huang, Shilong
    Li, Xin
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 870
  • [2] Mitophagy in cardiovascular diseases: molecular mechanisms, pathogenesis, and treatment
    Ajoolabady, Amir
    Chiong, Mario
    Lavandero, Sergio
    Klionsky, Daniel J.
    Ren, Jun
    TRENDS IN MOLECULAR MEDICINE, 2022, 28 (10) : 836 - 849
  • [3] Acetylation in cardiovascular diseases: Molecular mechanisms and clinical implications
    Yang, Mingjie
    Zhang, Yingmei
    Ren, Jun
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (10):
  • [4] Molecular and Cellular Mechanisms of Electronegative Lipoproteins in Cardiovascular Diseases
    Ke, Liang-Yin
    Law, Shi Hui
    Mishra, Vineet Kumar
    Parveen, Farzana
    Chan, Hua-Chen
    Lu, Ye-Hsu
    Chu, Chih-Sheng
    BIOMEDICINES, 2020, 8 (12) : 1 - 21
  • [5] Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
    Chen, Runkai
    Zhang, Hongrui
    Tang, Botao
    Luo, Yukun
    Yang, Yufei
    Zhong, Xin
    Chen, Sifei
    Xu, Xinjie
    Huang, Shengkang
    Liu, Canzhao
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [6] Role of A1 adenosine receptor in cardiovascular diseases: Bridging molecular mechanisms with therapeutic opportunities
    Parichatikanond, Warisara
    Duangrat, Ratchanee
    Nuamnaichati, Narawat
    Mangmool, Supachoke
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2025, 141
  • [7] Heavy Metal Exposure-Induced Cardiovascular Diseases: Molecular Mechanisms and Therapeutic Role of Antioxidants
    Ponnusamy, Bhuvaneswari
    Veeraraghavan, Vishnu Priya
    Al-Huseini, Isehaq
    Woon, Choy Ker
    Jayaraman, Selvaraj
    Sirasanagandla, Srinivasa Rao
    CURRENT MEDICINAL CHEMISTRY, 2024,
  • [8] The Role of Platelets in Cardiovascular Disease: Molecular Mechanisms
    Papapanagiotou, Angeliki
    Daskalakis, Georgios
    Siasos, Gerasimos
    Gargalionis, Antonios
    Papavassiliou, Athanasios G.
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (29) : 4493 - 4505
  • [9] Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease
    Chen, Jingnan
    Wang, Xitong
    Xia, Tian
    Bi, Yanhua
    Liu, Bin
    Fu, Junfen
    Zhu, Runzhi
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 142
  • [10] Is CD47 a potentially promising therapeutic target in cardiovascular diseases? - Role of CD47 in cardiovascular diseases
    Cheng, Quanli
    Gu, Junlian
    Adhikari, Binay Kumar
    Sun, Liguang
    Sund, Jian
    LIFE SCIENCES, 2020, 247